Oman vs Slovakia: Cause of death, by non-communicable diseases, ages 0-4, male
Oman
43.9%
in 2021
Slovakia
44.2%
in 2021
Oman rank
28th
Slovakia rank
26th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Oman
- Slovakia
How they compare
Slovakia currently reports 44.2% against 43.9% in Oman, a difference of 0.3%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Oman ahead.
Oman ranks 28th and Slovakia ranks 26th of 185 countries.
Across the 3 decades both report, Oman averaged higher in 1 and Slovakia in 2.
Head to head by decade
| Decade | Oman | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.7% | 37.3% | 5.3% | Oman |
| 2010s | 43.6% | 45.3% | 1.7% | Slovakia |
| 2020s | 44.1% | 45.1% | 1.0% | Slovakia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Oman or Slovakia?
- Slovakia, at 44.2% against 43.9% in Oman as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Oman and Slovakia?
- 0.3%, with Slovakia ahead.
- How many years of comparable data are there for Oman and Slovakia?
- 6 years are reported by both, from 2000 to 2021.
- How do Oman and Slovakia rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Oman ranks 28th and Slovakia ranks 26th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.